Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Unlock Free Earnings Estimates
Kezar Life Sciences | 10-K: FY2024 Annual Report
Mar 25 07:48 ET
Kezar Life Sciences | 8-K: Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter and Year End 2024 Financial
Mar 25 07:44 ET
Kezar Life Sciences | 10-Q: Q3 2024 Earnings Report
Nov 12, 2024 16:27 ET
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 12, 2024 16:13 ET
Read more